Incidence and effect of secondary cardiac amyloidosis on outcomes of patients with t(11;14) multiple myeloma
BackgroundThe t(11;14)(q13;32) is a common chromosome translocation in multiple myeloma (MM), but its prognostic value remains controversial. Immunoglobulin light chain amyloidosis is commonly secondary to multiple myeloma, which can rapidly cause heart failure and high mortality. We aimed to invest...
Main Authors: | Jinghua Wang, Shuo Yang, Pengjun Liao, Lingji Zeng, Wei Ling, Li Wan, Jianyu Weng, Liye Zhong |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2022-09-01
|
Series: | Frontiers in Cardiovascular Medicine |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fcvm.2022.994384/full |
Similar Items
-
AL Amyloidosis and Multiple Myeloma: A Complex Scenario in Which Cardiac Involvement Remains the Key Prognostic Factor
by: Rafael Ríos-Tamayo, et al.
Published: (2023-07-01) -
Ascites in the Course of Plasma Cell Myeloma Complicated by AL Amyloidosis
by: Jakub Debski, et al.
Published: (2018-02-01) -
Extensive Amyloid Purpura: An Unusual Presentation of Myeloma-associated Light Chain Amyloidosis
by: Nor Fazil Jaber, et al.
Published: (2023-06-01) -
CD20 expression: A risk stratification factor for newly diagnosed multiple myeloma with t(11;14)
by: Yuan Jian, et al.
Published: (2022-12-01) -
Lingual amyloidosis associated to multiple myeloma: case report
by: Gustavo André LEAL, et al.
Published: (2022-09-01)